164 related articles for article (PubMed ID: 32075450)
1. An echocardiographic predictor of contrast-induced nephropathy following percutaneous coronary intervention in acute coronary syndrome: aortic valve sclerosis.
Durak H; Erdoğan T; Çetin M; Kocaman SA; Durakoğlugil ME; Duman H; Ergül E; Şatıroğlu Ö
Scand Cardiovasc J; 2020 Aug; 54(4):227-231. PubMed ID: 32075450
[No Abstract] [Full Text] [Related]
2. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of the renal resistive index for contrast-induced nephropathy in patients with acute coronary syndrome.
Xu ZR; Chen J; Liu YH; Liu Y; Tan N
BMC Cardiovasc Disord; 2019 Feb; 19(1):36. PubMed ID: 30744553
[TBL] [Abstract][Full Text] [Related]
4. A novel risk assessment model of contrast-induced nephropathy after percutaneous coronary intervention in patients with diabetes.
Yao ZF; Shen H; Tang MN; Yan Y; Ge JB
Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):305-314. PubMed ID: 32991776
[TBL] [Abstract][Full Text] [Related]
5. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
[TBL] [Abstract][Full Text] [Related]
6. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
[TBL] [Abstract][Full Text] [Related]
7. Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
Kurtul A; Duran M; Yarlioglues M; Murat SN; Demircelik MB; Ergun G; Acikgoz SK; Sensoy B; Cetin M; Ornek E
Clin Cardiol; 2014 Aug; 37(8):485-92. PubMed ID: 24805995
[TBL] [Abstract][Full Text] [Related]
8. Association of the blood urea nitrogen-to-left ventricular ejection fraction ratio with contrast-induced nephropathy in patients with acute coronary syndrome who underwent percutaneous coronary intervention.
Kiris T; Avci E; Celik A
Int Urol Nephrol; 2019 Mar; 51(3):475-481. PubMed ID: 30604231
[TBL] [Abstract][Full Text] [Related]
9. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
[TBL] [Abstract][Full Text] [Related]
10. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
11. Canada Acute Coronary Syndrome Score: A Preprocedural Risk Score for Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.
Liu YH; Jiang L; Duan CY; He PC; Liu Y; Tan N; Chen JY
Angiology; 2017 Oct; 68(9):782-789. PubMed ID: 28135823
[TBL] [Abstract][Full Text] [Related]
12. Dosing of iodinated contrast volume: a new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome.
Raposeiras-Roubín S; Abu-Assi E; Ocaranza-Sánchez R; Alvarez-Álvarez B; Cambeiro-González C; Fandiño-Vaquero R; García-Castelo A; García-Acuña JM; González-Juanatey JR
Catheter Cardiovasc Interv; 2013 Nov; 82(6):888-97. PubMed ID: 23362013
[TBL] [Abstract][Full Text] [Related]
13. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.
Chaudhary AK; Pathak V; Kunal S; Shukla S; Pathak P
Indian Heart J; 2019; 71(4):303-308. PubMed ID: 31779857
[TBL] [Abstract][Full Text] [Related]
14. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
[TBL] [Abstract][Full Text] [Related]
15. Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention.
Zhang JY; Wang Q; Wang RT; Li F; Cheng HX; Lian K; Liu Y; Tao L
BMC Cardiovasc Disord; 2019 Jul; 19(1):160. PubMed ID: 31269899
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
Araujo GN; Wainstein MV; McCabe JM; Huang PH; Govindarajulu US; Resnic FS
J Interv Cardiol; 2016 Oct; 29(5):447-453. PubMed ID: 27377243
[TBL] [Abstract][Full Text] [Related]
17. Association of Neutrophil-to-lymphocyte Ratio with Contrast-induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.
Kurtul A; Yarlioglues M; Duran M; Murat SN
Heart Lung Circ; 2016 Jul; 25(7):683-90. PubMed ID: 26935164
[TBL] [Abstract][Full Text] [Related]
18. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
Gu G; Yuan X; Zhou Y; Liu D; Cui W
BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
[TBL] [Abstract][Full Text] [Related]
19. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.
Wickenbrock I; Perings C; Maagh P; Quack I; van Bracht M; Prull MW; Plehn G; Trappe HJ; Meissner A
Clin Res Cardiol; 2009 Dec; 98(12):765-72. PubMed ID: 19851800
[TBL] [Abstract][Full Text] [Related]
20. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
